Billings Clinic
Especially For:

Clinical Trials

Title   GI-First-Line Advanced Small Bowel Cancer
Description   NCCTG N0543-A Phase II Trial of Pharmacogenetic-Based Dosing of Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy for Advanced Small Bowel Adencarcinoma.
IRB Number   NCCTG N0543
Category   Gastrointestinal
Inclusion/Notes   Must send blood for UTG1A1 typing which takes one week prior to actually enrolling in study.

Please contact Tricia Montgomery, RN for additional inclusion/exclusion criteria.
Status   Active
Start Date   07/13/2007
Principal Investigator (PI)   Jorge Nieva, MD
Contact Name   Tricia Montgomery RN
Contact Email   tmontgomery@billingsclinic.org
Phone   (406) 435-7483
Fax   (406) 435-7489
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.